Pacific Biosciences Analyst Ratings
Scotiabank Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Cuts Target Price to $7
Pacific Biosciences (PACB) Receives a Buy From Scotiabank
Morgan Stanley Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $2
Piper Sandler Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $2
Stephens Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Cuts Target Price to $2.5
Piper Sandler Reaffirms Their Hold Rating on Pacific Biosciences (PACB)
Pacific Biosciences Analyst Ratings
Piper Sandler Keeps Their Hold Rating on Pacific Biosciences (PACB)
Pacific Biosciences Analyst Ratings
Pacific Biosciences: A Buy Rating Amidst Recovery and Growth Potential
Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know
Pacific Biosciences Analyst Ratings
Pacific Biosciences Analyst Ratings
Scotiabank Sticks to Its Buy Rating for Pacific Biosciences (PACB)
Pacific Biosciences Analyst Ratings
Pacific Biosciences Analyst Ratings
Pacific Biosciences Analyst Ratings
Pacific Biosciences Analyst Ratings
Pacific Biosciences Analyst Ratings